Conclusion
PTSD
Exposure-based treatment in patients with CA-PTSD yields considerable personal and societal economic benefits in this relatively costly and severely affected patient group. The current findings showed that the three exposure-based treatments do not differ in terms of outcomes and costs. As described elsewhere, the findings on the main clinical outcomes from the RCT showed that all treatment conditions resulted in large improvements in PTSD symptoms from baseline to 1 year follow-up (Cohen’s 